跳至主要内容
临床试验/EUCTR2009-013403-55-NL
EUCTR2009-013403-55-NL进行中(未招募)不适用

Early recognition and optimal treatment of delirium in patients with advanced cancer. - RCT Delirium in cancer patients

VU university medical center0 个研究点开始时间: 2009年7月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patient has been diagnosed with advanced cancer;
  • Age = 18;
  • Patient or his / her significant other speaks Dutch fluently.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • Delirium is due to alcohol withdrawal;
  • Patient has been diagnosed with glaucoma, Parkinson’s disease or dementia;
  • Patient is being treated with other neuroleptic medication or lithium (except for low dose neuroleptics used in the treatment of neuropathic pain;
  • Patient has another psychiatric disorder that is considered (by investigator) to interfere withassessment of delirium;
  • Patient had a QTc-interval of > 480 msec on ECG made on admission;
  • Patient has a history of neuroleptic malignant syndrome;
  • Patient has a history of convulsions.

研究者

发起方
VU university medical center

相似试验